Korean Drug Co., Ltd. (KOSDAQ:014570)
4,575.00
+110.00 (2.46%)
Last updated: Apr 1, 2025
Korean Drug Revenue
In the year 2024, Korean Drug had annual revenue of 73.00B KRW, down -10.29%. Korean Drug had revenue of 17.70B in the quarter ending December 31, 2024, a decrease of -7.37%.
Revenue
73.00B
Revenue Growth
-10.29%
P/S Ratio
0.66
Revenue / Employee
270.38M
Employees
270
Market Cap
48.72B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 73.00B | -8.37B | -10.29% |
Dec 31, 2023 | 81.37B | 1.39B | 1.74% |
Dec 31, 2022 | 79.98B | 5.52B | 7.41% |
Dec 31, 2021 | 74.47B | 7.68B | 11.49% |
Dec 31, 2020 | 66.79B | 11.26B | 20.28% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 300.87T |
SK hynix | 66.19T |
LG Energy Solution | 25.62T |
Samsung Biologics | 4,547.32B |
Hyundai Motor Company | 175.23T |
Celltrion | 3,557.30B |
Kia Corporation | 107.45T |
KB Financial Group | 15.01T |